Introduction Chronic Rhinosinusitis (CRS) may manifest phenotypically with or without nasal polyps (CRSw/sNP) and can be endotypically classified into Type 2 or Non-Type 2. Patients with Type 2 CRSwNP exhibit the highest risk of comorbid asthma. The objective of this study was to analyze sinonasal and asthma-related quality of life (QoL) in patients with comorbid asthma and primary diffuse CRS.
No takes yet. Share an insight, caveat, or question.
Marzouk et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: